Treatment with MPTP, a prodrug to the neurotoxin MPP+, which causes Parkinsonism symptoms by destroying the dopaminergic neurons, was shown to inhibit HIF-1α accumulation in mice and in dopaminergic cell lines (99). Here, HIF1A is linked to Parkinson disease.